Rockwell Automation maintained a recent focus on life sciences by taking a key role in a consortium forged to tackle pharmaceutical industry bottlenecks through digitalisation.

It is a founding member of the Digital CMC Consortium, a group established to streamline the chemistry, manufacturing and controls (CMC) elements of drug development which Rockwell Automation stated is currently hampering the sector due to a reliance on analogue methods.

The consortium describes itself as pre-competitive, meaning it focuses on establishing common ground on which companies can subsequently fight it out. The group produced its first two standardised digital specifications within six months and currently has eight organisations on board.

Rockwell Automation explained the work is needed because current CMC approaches still rely on “manual, document-based workflows”.

Digital upgrades are the only way to adapt to a sector in which treatments are becoming “more complex and personalised”, it stated.

Matt Weaver, VP of global industry life sciences, said the digital transformation of the sector “is not just about technology adoption, it is about building new ways of working”.

Rockwell Automation recently revealed the overall life sciences sector is waking up to the potential offered by digitalisation, though faces some challenges around data insights.

The post Rockwell joins pharma standards group appeared first on Mobile World Live.

OpenAI’s annualised revenue reportedly reached $50 billion in September, falling $20 billion short of estimates due to accounting discrepancies rather than a slowdown in demand.

The Financial Times (FT) reported financial documents viewed by investors put its annual revenue at $50 billion in September instead of the widely reported $70 billion.

The news site noted the shortfall was due to attempts by OpenAI’s own investor to provide a comparison to rival Anthropic’s annualised revenue run rate. CNBC reported Anthropic’s annualised run rate hit $65 billion by late July 2026.

While the $20 billion gap sounds like a sudden drop, OpenAI clarified to investors its direct revenue still grew by over 70% in Q3 2026 alone, according to FT.

Reuters and other news outlets reported OpenAI was approaching $70 billion in late September based on a more than ​twofold increase in enterprise sales since July.

FT explained the two AI players calculate revenue in different ways, with Anthropic including sales from cloud partners such as Amazon Web Services and Google while OpenAI does not.

Anthropic is reportedly targeting an IPO in November after the US midterm elections while OpenAI is targeting a listing next year.

The post OpenAI revenue short by $20B from estimates appeared first on Mobile World Live.